PhRMA president and CEO Stephen J. Ubl recently spoke with FOX Business anchor Neil Cavuto on his personal connection to the value of medical technology with his son’s type 1 diabetes diagnosis, the industry’s meeting with President Donald J. Trump and access and affordability challenges for patients.
Ensuring patients have access to the medicines they need is a top priority for the biopharmaceutical industry, and through our new initiative, The Value Collaborative™, we will convene a national dialogue to discuss new and innovative ways to pay for medicines.
Holly Campbell Holly Campbell is a deputy vice president of public affairs at PhRMA focusing on the cost and value of medicines. Prior to joining PhRMA, Holly worked for large and small public relations firms where she provided strategic communications counsel, media relations and partnership expertise to health care and pharmaceutical clients. In her free time, she enjoys taking barre classes, trying new restaurants and spending time with Boss and Poppy, her rescue pups.